Showing results (161-170 of 174) with videos related to
Sort By:
Pageof 18
Bioorganic & Medicinal Chemistry Letters|December 25, 2009
Synthesis and evaluation of two series of 4'-aza-carbocyclic nucleosides as adenosine A2A receptor agonistsDavid Beattie, Andrew Brearley, Zarin Brown, et al.Chemmedchem|February 17, 2025
The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to LeadJean Quancard, Anders Bach, Chiara Borsari, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|September 30, 2014
Batch versus flow photochemistry: a revealing comparison of yield and productivityLuke D Elliott, Jonathan P Knowles, Paul J Koovits, et al.Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Discovery, SAR, synthesis, pharmacokinetic and biochemical characterization of A-192411: a novel fungicidal lipopeptide-(I)Weibo Wang, Qun Li, Lisa Hasvold, et al.Journal of Medicinal Chemistry|May 12, 2025
Cell-Based Progression of Spiroindoline Phenotypic Hits Leads to the Identification of Compounds with Diverging Parasitological Profiles against the Human Malaria Parasite Plasmodium falciparumJean Dam, Grant A Boyle, André Horatscheck, et al.Bioorganic & Medicinal Chemistry Letters|July 14, 2009
7-Azaindole-3-acetic acid derivatives: potent and selective CRTh2 receptor antagonistsDavid A Sandham, Claire Adcock, Kamlesh Bala, et al.Bioorganic & Medicinal Chemistry Letters|August 7, 2012
Development of isoform selective PI3-kinase inhibitors as pharmacological tools for elucidating the PI3K pathwayIan Bruce, Mohammed Akhlaq, Graham C Bloomfield, et al.Frontiers in Pharmacology|May 23, 2017
Identification of a Novel Allosteric Inhibitory Site on Tryptophan Hydroxylase 1 Enabling Unprecedented Selectivity Over all Related HydroxylasesMike Petrassi, Rob Barber, Celine Be, et al.ACS Medicinal Chemistry Letters|May 20, 2017
Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of AsthmaDavid A Sandham, Lucy Barker, Lyndon Brown, et al.ACS Medicinal Chemistry Letters|September 27, 2017
Correction to "Discovery of Fevipiprant (NVP-QAW039), a Potent and Selective DP2 Receptor Antagonist for Treatment of Asthma"David A Sandham, Lucy Barker, Lyndon Brown, et al.Pageof 18